|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Immunology
:
Immunosupressants
:
Daclizumab
New insights into how anti-rejection drug daclizumab helps MS patients
Discovery of the mechanism of a drug being tested for the treatment of multiple sclerosis (MS) has revealed that it's not only more effective than first thought, but might also help in the management of other autoimmune diseases, organ transplant rejection and even cancer.
Mar 29, 2006, 06:47
Latest Research
:
Immunology
:
Immunosupressants
:
Daclizumab
Daclizumab is effective in reducing rejection in heart transplantation
A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.
Jun 30, 2005, 06:50
|
